Found: 53
Select item for more details and to access through your institution.
Estimated lifetime benefit of novel pharmacological therapies in patients with type 2 diabetes and chronic kidney disease: A joint analysis of randomized controlled clinical trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3327, doi. 10.1111/dom.15232
- By:
- Publication type:
- Article
Gender- and age-specific rates of heart failure and other adverse cardiovascular outcomes in systemic sclerosis.
- Published in:
- Rheumatology, 2022, v. 61, n. 11, p. 4374, doi. 10.1093/rheumatology/keac072
- By:
- Publication type:
- Article
Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Insights into foundational therapies for heart failure with reduced ejection fraction.
- Published in:
- Clinical Cardiology, 2022, v. 45, p. S26, doi. 10.1002/clc.23847
- By:
- Publication type:
- Article
Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics.
- Published in:
- European Heart Journal, 2023, v. 44, n. 31, p. 2966, doi. 10.1093/eurheartj/ehad341
- By:
- Publication type:
- Article
Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER.
- Published in:
- European Heart Journal, 2023, v. 44, n. 24, p. 2170, doi. 10.1093/eurheartj/ehad276
- By:
- Publication type:
- Article
Serum bicarbonate and congestion: a potential biomarker for identifying and guiding management in diuretic resistance?
- Published in:
- European Heart Journal, 2023, v. 44, n. 22, p. 2006, doi. 10.1093/eurheartj/ehad209
- By:
- Publication type:
- Article
A welcome 'failure' of gliflozins: blood pressure reduction in heart failure.
- Published in:
- European Heart Journal, 2023, v. 44, n. 5, p. 408, doi. 10.1093/eurheartj/ehac712
- By:
- Publication type:
- Article
Effect of dapagliflozin in patients with diabetes and heart failure with mildly reduced or preserved ejection fraction according to background glucose‐lowering therapy: A pre‐specified analysis of the DELIVER trial.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 7, p. 1539, doi. 10.1002/ejhf.3269
- By:
- Publication type:
- Article
Dapagliflozin and quality of life measured using the EuroQol 5‐dimension questionnaire in patients with heart failure with reduced and mildly reduced/preserved ejection fraction.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 7, p. 1524, doi. 10.1002/ejhf.3263
- By:
- Publication type:
- Article
Calcium channel blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 12, p. 2202, doi. 10.1002/ejhf.3044
- By:
- Publication type:
- Article
Practical algorithms for early diagnosis of heart failure and heart stress using NT‐proBNP: A clinical consensus statement from the Heart Failure Association of the ESC.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 11, p. 1891, doi. 10.1002/ejhf.3036
- By:
- Publication type:
- Article
Declining risk of heart failure hospitalization following first acute myocardial infarction in Scotland between 1991–2016.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1213, doi. 10.1002/ejhf.2965
- By:
- Publication type:
- Article
Heart failure diagnosis in the general community – Who, how and when? A clinical consensus statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1185, doi. 10.1002/ejhf.2946
- By:
- Publication type:
- Article
Potential global impact of sodium–glucose cotransporter‐2 inhibitors in heart failure.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 7, p. 999, doi. 10.1002/ejhf.2864
- By:
- Publication type:
- Article
Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N‐terminal pro‐B‐type natriuretic peptide level: insights from the GALACTIC‐HF trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 2, p. 248, doi. 10.1002/ejhf.2763
- By:
- Publication type:
- Article
Health‐related quality of life in acute heart failure: association between patient‐reported symptoms and markers of congestion.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 1, p. 54, doi. 10.1002/ejhf.2699
- By:
- Publication type:
- Article
Dapagliflozin in patients with heart failure with mildly reduced and preserved ejection fraction treated with a mineralocorticoid receptor antagonist or sacubitril/valsartan.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2307, doi. 10.1002/ejhf.2722
- By:
- Publication type:
- Article
Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA‐HF.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 6, p. 1066, doi. 10.1002/ejhf.2433
- By:
- Publication type:
- Article
Eligibility for pharmacological therapies in heart failure with reduced ejection fraction: implications of the new Chronic Kidney Disease Epidemiology Collaboration creatinine equation for estimating glomerular filtration rate.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 861, doi. 10.1002/ejhf.2460
- By:
- Publication type:
- Article
Effect of sacubitril/valsartan on investigator‐reported ventricular arrhythmias in PARADIGM‐HF.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 3, p. 551, doi. 10.1002/ejhf.2419
- By:
- Publication type:
- Article
Dapagliflozin and atrial fibrillation in heart failure with reduced ejection fraction: insights from DAPA‐HF.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 3, p. 513, doi. 10.1002/ejhf.2381
- By:
- Publication type:
- Article
Efficacy of dapagliflozin in heart failure with reduced ejection fraction according to body mass index.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Sodium–glucose co‐transporter 2 inhibitors—the first successful treatment for heart failure with preserved ejection fraction?
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 8, p. 1256, doi. 10.1002/ejhf.2108
- By:
- Publication type:
- Article
Effect of dapagliflozin on anaemia in DAPA‐HF.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 4, p. 617, doi. 10.1002/ejhf.2132
- By:
- Publication type:
- Article
Efficacy and safety of dapagliflozin according to aetiology in heart failure with reduced ejection fraction: insights from the DAPA‐HF trial.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 4, p. 601, doi. 10.1002/ejhf.2124
- By:
- Publication type:
- Article
Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA-HF.
- Published in:
- 2021
- By:
- Publication type:
- journal article
OUTSTEP‐HF: re‐evaluating the role of physical activity measures in drug and device development in heart failure.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 1, p. 136, doi. 10.1002/ejhf.2106
- By:
- Publication type:
- Article
SOLOIST‐WHF and updated meta‐analysis: sodium–glucose co‐transporter 2 inhibitors should be initiated in patients hospitalized with worsening heart failure.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 1, p. 27, doi. 10.1002/ejhf.2075
- By:
- Publication type:
- Article
Prevalence and incidence of intra‐ventricular conduction delays and outcomes in patients with heart failure and reduced ejection fraction: insights from PARADIGM‐HF and ATMOSPHERE.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 12, p. 2370, doi. 10.1002/ejhf.1972
- By:
- Publication type:
- Article
Cost‐effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health‐economic analysis of DAPA‐HF.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2147, doi. 10.1002/ejhf.1978
- By:
- Publication type:
- Article
Predictors of sudden cardiac death in high-risk patients following a myocardial infarction.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fraction.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effect of sacubitril/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HF.
- Published in:
- European Journal of Heart Failure. Supplements, 2022, v. 24, n. 3, p. 551, doi. 10.1002/ejhf.2419
- By:
- Publication type:
- Article
Dapagliflozin and atrial fibrillation in heart failure with reduced ejection fraction: insights from DAPA-HF.
- Published in:
- European Journal of Heart Failure. Supplements, 2022, v. 24, n. 3, p. 513, doi. 10.1002/ejhf.2381
- By:
- Publication type:
- Article
Intravenous iron and SGLT2 inhibitors in iron‐deficient patients with heart failure and reduced ejection fraction.
- Published in:
- ESC Heart Failure, 2024, v. 11, n. 4, p. 1875, doi. 10.1002/ehf2.14742
- By:
- Publication type:
- Article
Within trial comparison of survival time projections from short‐term follow‐up with long‐term follow‐up findings.
- Published in:
- ESC Heart Failure, 2022, v. 9, n. 5, p. 3655, doi. 10.1002/ehf2.13731
- By:
- Publication type:
- Article
Sex differences in congestive markers in patients hospitalized for acute heart failure.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 3, p. 1784, doi. 10.1002/ehf2.13300
- By:
- Publication type:
- Article
Rationale and methods of a randomized trial evaluating the effect of neprilysin inhibition on left ventricular remodelling.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 1, p. 129, doi. 10.1002/ehf2.13137
- By:
- Publication type:
- Article
Effect of Neprilysin Inhibition on Alzheimer Disease Plasma Biomarkers: A Secondary Analysis of a Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2024, v. 81, n. 2, p. 197, doi. 10.1001/jamaneurol.2023.4719
- By:
- Publication type:
- Article
Effect of Omecamtiv Mecarbil on Exercise Capacity in Chronic Heart Failure With Reduced Ejection Fraction: The METEORIC-HF Randomized Clinical Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction : A Post Hoc Analysis of the DAPA-HF Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction: A Post Hoc Analysis of the DAPA-HF Trial.
- Published in:
- Annals of Internal Medicine, 2022, v. 175, n. 6, p. 820, doi. 10.7326/M21-4776
- By:
- Publication type:
- Article
Sex differences in procedural and clinical outcomes following rotational atherectomy.
- Published in:
- Catheterization & Cardiovascular Interventions, 2020, v. 95, n. 2, p. 232, doi. 10.1002/ccd.28373
- By:
- Publication type:
- Article
Use of direct oral anticoagulants in thromboembolic disease.
- Published in:
- Prescriber, 2016, v. 27, n. 8, p. 15, doi. 10.1002/psb.1487
- By:
- Publication type:
- Article
Diagnosis and pharmacological management of stable angina.
- Published in:
- Prescriber, 2016, v. 27, n. 5, p. 27, doi. 10.1002/psb.1459
- By:
- Publication type:
- Article
Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF.
- Published in:
- European Heart Journal, 2021, v. 42, n. 36, p. 3727, doi. 10.1093/eurheartj/ehab560
- By:
- Publication type:
- Article
The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context.
- Published in:
- European Heart Journal, 2021, v. 42, n. 13, p. 1199, doi. 10.1093/eurheartj/ehz916
- By:
- Publication type:
- Article
Effects of dapagliflozin in DAPA-HF according to background heart failure therapy.
- Published in:
- European Heart Journal, 2020, v. 41, n. 25, p. 2379, doi. 10.1093/eurheartj/ehaa183
- By:
- Publication type:
- Article
How robust are clinical trials in heart failure?
- Published in:
- European Heart Journal, 2017, v. 38, n. 5, p. 338, doi. 10.1093/eurheartj/ehw427
- By:
- Publication type:
- Article